-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Downgrades Conmed to Hold, Lowers Price Target to $55

Benzinga·04/28/2025 15:04:30
Listen to the news
Stifel analyst Rick Wise downgrades Conmed (NYSE:CNMD) from Buy to Hold and lowers the price target from $75 to $55.